000 | 01950 a2200613 4500 | ||
---|---|---|---|
005 | 20250517095432.0 | ||
264 | 0 | _c20170719 | |
008 | 201707s 0 0 eng d | ||
022 | _a1573-2584 | ||
024 | 7 |
_a10.1007/s11255-016-1314-z _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKara, Onder | |
245 | 0 | 0 |
_aPrognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma. _h[electronic resource] |
260 |
_bInternational urology and nephrology _cAug 2016 |
||
300 |
_a1253-1260 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aBiopsy, Needle |
650 | 0 | 4 |
_aCarcinoma, Renal Cell _xmortality |
650 | 0 | 4 | _aCause of Death |
650 | 0 | 4 | _aCell Differentiation |
650 | 0 | 4 | _aDatabases, Factual |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 |
_aKidney Neoplasms _xmortality |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Grading |
650 | 0 | 4 |
_aNephrectomy _xmethods |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aRhabdoid Tumor _xpathology |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 |
_aSarcoma _xpathology |
650 | 0 | 4 | _aStatistics, Nonparametric |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aMaurice, Matthew J | |
700 | 1 | _aZargar, Homayoun | |
700 | 1 | _aMalkoc, Ercan | |
700 | 1 | _aAkca, Oktay | |
700 | 1 | _aAndrade, Hiury S | |
700 | 1 | _aRamirez, Daniel | |
700 | 1 | _aCaputo, Peter A | |
700 | 1 | _aNelson, Ryan J | |
700 | 1 | _aRini, Brian | |
700 | 1 | _aKaouk, Jihad H | |
773 | 0 |
_tInternational urology and nephrology _gvol. 48 _gno. 8 _gp. 1253-1260 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11255-016-1314-z _zAvailable from publisher's website |
999 |
_c26050942 _d26050942 |